Cognition Therapeutics
CGTX
40 hedge funds and large institutions have $1.99M invested in Cognition Therapeutics in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 14 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
2.66% less ownership
Funds ownership: 13.26% → 10.6% (-2.7%)
13% less funds holding
Funds holding: 46 → 40 (-6)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
77% less capital invested
Capital invested by funds: $8.82M → $1.99M (-$6.82M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$204K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$145K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$97.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$81.3K |
| 5 |
VF
Virtu Financial
New York
|
+$59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$1.08M |
| 2 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$600K |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$499K |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
-$232K |
| 5 |
CCM
Corsair Capital Management
New York
|
-$129K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SSB
51
Sandy Spring Bank
Olney,
Maryland
| – | -$3.32K | -2,000 | Closed |
|
|
OWA
52
Opal Wealth Advisors
Jericho,
New York
| – | -$830 | -500 | Closed |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -338 | Closed |
|
54
Fidelity Investments
Boston,
Massachusetts
| – | -$103 | -100 | -99% |
|
CGTX Hedge Fund Activity: Q3 2024 in Review
40 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q3 2024, worth a combined $1.99M — down 77% from $8.82M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CGTX and 9 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was UBS Group, opening a new position worth an estimated $204K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.08M sold.
- 40 institutional investors held Cognition Therapeutics (CGTX) as of Q3 2024, down from 46 in Q2 2024.
- Funds reported $1.99M of Cognition Therapeutics stock for Q3 2024, down 77% quarter-over-quarter.
- 9 funds opened new Cognition Therapeutics positions in Q3 2024 and 14 closed out, a net change of -5 holders.
- The largest Cognition Therapeutics buyer in Q3 2024 was UBS Group, an estimated $204K added.
- The largest Cognition Therapeutics seller in Q3 2024 was AWM Investment Company, an estimated $1.08M sold.
Based on aggregated 13F filings for Q3 2024.